The medtech industry’s seemingly unstoppable rise over the past several weeks shows no signs of slowing down. For the fourth time in five weeks, and for the third consecutive week, the MassDevice MedTech 100 Index — which includes stocks of the world’s largest medical device companies — hit an all-time high. Previous highs have largely been […]
Dentsply Sirona
Dentsply acquires Byte clear aligners for $1.04B
Dentsply Sirona (NSDQ:XRAY) announced that it acquired clear dental aligner maker Byte in an all-cash deal worth $1.04 billion. According to a news release, Byte possesses a leadership position in the direct-to-consumer clear aligner market, which Dentsply can now add to its SureSmile clear aligner business while strengthening its connection with dental professionals to drive growth. […]
Dentsply Sirona names chief accounting officer
Dentsply Sirona recently announced that it appointed Ranjit Chadha as chief accounting officer, effective August 31. Chadha will be responsible for the company’s filings with the Securities and Exchange Commission. He replaces Jorge Gomez, who will become the company’s executive VP and chief financial officer. Chadha most recently served as senior VP of corporate financial […]
Moody’s lowers its medical device industry earnings forecast
Medical device industry earnings will remain flat over the next 12 to 18 months as people hold off on medical procedures amid the COVID-19 pandemic and resulting recession, according to a new report from Moody’s. Moody’s had previously projected of 2–4% annual growth. “While underlying positive trends remain, including ongoing innovation and favorable longterm demographics, […]
MedTech 100 roundup: Stocks open strong in May
Medtech stocks took a dip as April came to a close, but opened May with a strong week as the COVID-19 pandemic continues to affect the economy. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 83.98 points at the end of last week (May 8). That […]
Dentsply Sirona drops despite Street-beating Q1
Dentsply Sirona (NSDQ:XRAY) shares dipped today despite preliminary first-quarter results that topped the consensus forecast. The Charlotte, N.C.-based company posted losses of -$139.9 million, or -63¢ per share, on sales of $874.3 million for the three months ended March 31, 2020, for a bottom-line slide from profits of $39.2 million this time last year on a […]
How will coronavirus affect medtech companies that rely on elective surgeries?
One thing is likely to hurt some medtech companies more than others during the coronavirus pandemic: an elective surgical procedure slowdown. This thought had begun to emerge last week among industry watchers, but a pair of tweets over the weekend gained thousands of “likes” and retweets. The American College of Surgeons called for hospitals to […]
Dentsply Sirona beats Street on 4Q sales, misses on earnings
Dentsply Sirona (NSDQ:XRAY) shares took a marginal dip today on fourth-quarter results that had mixed results compared to the consensus forecast. The York, Pa.–based dental equipment maker posted profits of $102 million, or 46¢ per share, on sales of $1.1 billion for the three months ended Dec. 31, 2019, for a monstrous bottom-line gain from […]
Dentsply Sirona raises guidance as Q3 earnings beat The Street
Dentsply Sirona (NSDQ:XRAY) shares are up today on third-quarter results that topped the consensus forecast. The York, Pa.–based dental equipment maker posted profits of $85 million, or 38¢ per share, on sales of $962.1 million for the three months ended Sept. 30, tripling its bottom line from the same quarter last year on sales growth of […]
Dentsply Q2 earnings beat the Street, sales slip
Dentsply Sirona (NSDQ:XRAY) reported second-quarter earnings today that beat the consensus forecast on Wall Street and raised its outlook for the rest of the year. The York, Penn.-based company reported profits of $36.4 million, or 0.16¢ per diluted share, on sales of $1.01 billion for the three months ended June 30, 2019. For the second […]
Report: “Unglamorous” medtech outshines biopharma in 2019
Medtech merger and acquisition deal announcements slowed in the first half of 2019, but the industry got a boost from Verily’s $1 billion round of funding — the largest ever for a medtech firm. The Verily round was twice the size of the biggest-ever VC deal for a biotech company, according to the Vantage Half-Year […]
